The Patent Finder

Acelrx Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Acelrx Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Back to Acelrx Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 8,252,328Bioadhesive Drug Formulations for Oral Transmucosal Delivery
In force
 · Medium confidence
In forceMedium confidence
US 8,535,714Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil for Treatment of Pain
In force
 · Medium confidence
In forceMedium confidence
US 9,320,710Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil for Treatment of Pain
In force
 · High confidence
In forceHigh confidence
US 9,744,129Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil for Treatment of Pain
In force
 · High confidence
In forceHigh confidence
US 10,245,228Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil for Treatment of Pain
In force
 · High confidence
In forceHigh confidence
US 10,342,762Small-Volume Oral Transmucosal Dosage Forms
In force
 · Medium confidence
In forceMedium confidence
US 10,507,180Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil for Treatment of Pain
In force
 · High confidence
In forceHigh confidence
US 8,226,978Small Volume Oral Transmucosal Dosage Forms Containing Sufentanil for Treatment of Pain
In force
 · Medium confidence
In forceMedium confidence
US 8,252,329Bioadhesive Drug Formulations for Oral Transmucosal Delivery
In force
 · Medium confidence
In forceMedium confidence
US 8,231,900Small-Volume Oral Transmucosal Dosage
In force
 · Medium confidence
In forceMedium confidence
10 of 33 records shown.
Pro members see all 33.
Pro members: see all 33 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited